Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

Abstract Background and aims Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the clinical outcomes and treatment benefits of SGLT2i versus ARNI...

Full description

Bibliographic Details
Main Authors: Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung, Tien-Hsing Chen
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Diabetology & Metabolic Syndrome
Subjects:
ARNI
SGLT2i
Heart failure
Renal function
Diabetes mellitus
Online Access:https://doi.org/10.1186/s13098-023-01081-2

Similar Items

Similar Items